1
|
Colleti Junior J, Caino FR, Teixeira R, Carvalho WBD. Fulminant acute hepatitis in pediatrics in Latin America and the Caribbean. Rev Assoc Med Bras (1992) 2019; 65:914-921. [DOI: 10.1590/1806-9282.65.6.914] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2019] [Accepted: 02/10/2019] [Indexed: 11/21/2022] Open
Abstract
SUMMARY OBJECTIVE: The objective of this review was to investigate the epidemiology of Fulminant Acute Hepatitis in Latin America and the Caribbean and identify possible measures aimed at a better understanding and improvement of patient support. METHODS: We used 3 different researchers to investigate the topic of Fulminant Acute Hepatitis in pediatrics in papers published by Latin American and Caribbean authors in the PubMed and SciELO databases from 2000 to 2016. RESULTS: We found 2,879 articles in the databases searched. After selecting and excluding articles according to the study protocol, 68 remaining studies were obtained for analysis. A total of 1,265 cases of acute fulminant hepatitis were detected, with a predominance of females (42.9%), followed by males (39.4%), with no description of sex in 17.7% of the cases. The main cause was viral hepatitis, representing 45.1% of the cases. The hepatitis A virus was responsible for 34.7% of the total cases and 76.9% of the infectious causes. Of the total number of patients, 26.9% were described as idiopathic, and 11.5% had no cause. CONCLUSION: The preventable causes of Fulminant Acute Hepatitis include hepatitis viruses - primarily the hepatitis A virus - and poisoning. Active vaccination, basic sanitation, and public awareness can reduce the number of patients and, consequently, the costs of liver transplantation due to these causes.
Collapse
|
2
|
Feier F, Antunes E, D'Agostino D, Varela-Fascinetto G, Jarufe N, Patillo JC, Vera A, Carrasco F, Kondo M, Porta G, Chapchap P, Seda-Neto J. Pediatric liver transplantation in Latin America: Where do we stand? Pediatr Transplant 2016; 20:408-16. [PMID: 26841316 DOI: 10.1111/petr.12679] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 12/30/2015] [Indexed: 12/11/2022]
Abstract
LT started in LA in 1968, and pediatric LT records are available starting in the 1990s. Currently, eight countries perform pediatric LT in LA. Registries by national organizations fail to report robust data on pediatric LT. The aim of this paper was to report on the pediatric LT activity in LA. Data were gathered retrospectively through information available in the national registries websites and from local centers. Of the eight countries that report pediatric LT activity, Brazil, Argentina, Mexico, and Colombia have adequate registries of the numbers of LT performed. These countries concentrate most of the activity for pediatric LT. A total of 4593 pediatric LT were reported in LA. Websites for national organizations do not provide open data on post-transplant survival rates or waiting list mortality. The information herein is based on reports by local centers. Overall, survival from select centers is similar to that reported on North American and European registries, between 80 and 90% in the first year post-transplant. In conclusion, pediatric LT activity is growing in LA, especially in Brazil and Argentina. However, the lack of an appropriate LA registry restricts the assessment of quality and therefore restricts interventions aimed at quality improvements in different regions.
Collapse
Affiliation(s)
- Flavia Feier
- Hepatology and Liver Transplantation Group, Hospital Sirio-Libanes, São Paulo, Brazil.,Hepatology and Liver Transplantation Group, AC Camargo Cancer Center, São Paulo, Brazil
| | - Eduardo Antunes
- Hepatology and Liver Transplantation Group, Hospital Sirio-Libanes, São Paulo, Brazil.,Hepatology and Liver Transplantation Group, AC Camargo Cancer Center, São Paulo, Brazil
| | - Daniel D'Agostino
- Hepatology and Liver Transplantation, Hospital Italiano, Buenos Aires, Argentina
| | | | - Nicolas Jarufe
- Liver Transplantation, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile
| | - Juan C Patillo
- Liver Transplantation, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile
| | - Alonso Vera
- Transplant Department, University Hospital Fundación Santa Fe de Bogota, Bogota, Colombia
| | - Felix Carrasco
- Hepatobiliary Surgery Department, Hospital Nacional Guillermo Almenara, Lima, Peru
| | - Mario Kondo
- Hepatology and Liver Transplantation Group, Hospital Sirio-Libanes, São Paulo, Brazil.,Hepatology and Liver Transplantation Group, AC Camargo Cancer Center, São Paulo, Brazil
| | - Gilda Porta
- Hepatology and Liver Transplantation Group, Hospital Sirio-Libanes, São Paulo, Brazil.,Hepatology and Liver Transplantation Group, AC Camargo Cancer Center, São Paulo, Brazil
| | - Paulo Chapchap
- Hepatology and Liver Transplantation Group, Hospital Sirio-Libanes, São Paulo, Brazil
| | - Joao Seda-Neto
- Hepatology and Liver Transplantation Group, Hospital Sirio-Libanes, São Paulo, Brazil.,Hepatology and Liver Transplantation Group, AC Camargo Cancer Center, São Paulo, Brazil
| |
Collapse
|